[1] Adams MC, Turkington TG, Wilson JM, et al. A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol, 2010, 195(2): 310-320.  doi: 10.2214/AJR.10.4923
[2] Kubota K, Watanabe H, Murata Y, et al. Effects of blood glucose level on FDG uptake by liver: a FDG-PET/CT study. Nucl Med Biol, 2011, 38(3): 347-351.
[3] Kaneta T, Hakamatsuka T, Takanami K, et al. Evaluation of the relationship between physiological FDG uptake in the heart and age, blood glucose level, fasting period, and hospitalization. Ann Nucl Med, 2006, 20(3): 203-208.  doi: 10.1007/BF03027431
[4] Hadi M, Bacharach SL, Whatley M, et al. Glucose and insulin variations in patients during the time course of a FDG-PET study and implications for the "glucose-corrected" SUV. Nucl Med Biol, 2008, 35(4): 441-445.
[5]

William DT, Elisabeth B, H Konrad Müller-Hermelink, et al. Patho-logy and genetics: tumors of the lung, pleura, thymus and heart. Lyon: IARC Press, 2004: 35.

[6] Wahl RL, Jacene H, Kasamon Y, et al. From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors. J Nucl Med, 2009, 50 suppl 1: S122-150.